Cost–utility analysis of an integrated genetic/epigenetic test for assessing risk for coronary heart disease
Aim: New epigenetically based methods for assessing risk for coronary heart disease may
be more sensitive but are generally more costly than current methods. To understand their …
be more sensitive but are generally more costly than current methods. To understand their …
Cost-utility analysis of an integrated genetic/epigenetic test for assessing risk for coronary heart disease.
Y Jung, D Frisvold, T Dogan, M Dogan, R Philibert - Epigenomics, 2021 - europepmc.org
Aim: New epigenetically based methods for assessing risk for coronary heart disease may
be more sensitive but are generally more costly than current methods. To understand their …
be more sensitive but are generally more costly than current methods. To understand their …
Cost-utility analysis of an integrated genetic/epigenetic test for assessing risk for coronary heart disease
Y Jung, D Frisvold, T Dogan, M Dogan, R Philibert - Epigenomics, 2021 - iro.uiowa.edu
New epigenetically based methods for assessing risk for coronary heart disease may be
more sensitive but are generally more costly than current methods. To understand their …
more sensitive but are generally more costly than current methods. To understand their …
Cost-utility analysis of an integrated genetic/epigenetic test for assessing risk for coronary heart disease
Y Jung, D Frisvold, T Dogan, M Dogan… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Aim: New epigenetically based methods for assessing risk for coronary heart disease may
be more sensitive but are generally more costly than current methods. To understand their …
be more sensitive but are generally more costly than current methods. To understand their …